MedPath

Effect van Mirabegron op de urethrale druk tijdens urodynamisch onderzoek

Recruiting
Conditions
urinary urgency, urinarinary incontinence, over active bladder symptoms
Registration Number
NL-OMON26653
Lead Sponsor
P. Groenendijk, Medisch Centrum Haaglanden, den haag
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
75
Inclusion Criteria

Female patients, above age of 18, mentally fit to consent and indication for treatment with Mirabegron. Bothersome OAB symptoms. Voiding diary volume urine less then 2200ml.

•Signed informed consent

Exclusion Criteria

• Contraindications for the use of Mirabegron (severely impaired kidney- or liver function)

•Sediment + or clinical signs of UTI at the start of the urodynamic investigation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Effect of mirabegron on urethral pressure variations
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath